These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1428034)

  • 1. Endoscopic sclerotherapy versus propranolol in prevention of recurrent variceal bleeding in patients with child's B and C cirrhosis: a preliminary report.
    Dwivedi M; Bhargava DK; Ramachandran K
    Indian J Gastroenterol; 1992 Apr; 11(2):68-70. PubMed ID: 1428034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal-systemic encephalopathy in a randomized controlled trial of endoscopic sclerotherapy versus emergency portacaval shunt treatment of acutely bleeding esophageal varices in cirrhosis.
    Orloff MJ; Isenberg JI; Wheeler HO; Haynes KS; Horacio JB; Rapier R; Vaida F; Hye RJ
    Ann Surg; 2009 Oct; 250(4):598-610. PubMed ID: 19730244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial.
    Alexandrino PT; Alves MM; Pinto Correia J
    J Hepatol; 1988 Oct; 7(2):175-85. PubMed ID: 3057063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy.
    Fleig WE; Stange EF; Hunecke R; Schönborn W; Hurler U; Rainer K; Gaus W; Ditschuneit H
    Hepatology; 1987; 7(2):355-61. PubMed ID: 3549507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial.
    Avgerinos A; Rekoumis G; Klonis C; Papadimitriou N; Gouma P; Pournaras S; Raptis S
    J Hepatol; 1993 Sep; 19(2):301-11. PubMed ID: 8301065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding.
    Westaby D; Polson RJ; Gimson AE; Hayes PC; Hayllar K; Williams R
    Hepatology; 1990 Mar; 11(3):353-9. PubMed ID: 2179096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy].
    Martin T; Taupignon A; Lavignolle A; Perrin D; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(11):833-7. PubMed ID: 1769473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of emergency endoscopic sclerotherapy for active variceal bleeding due to cirrhosis of the liver, non-cirrhotic portal fibrosis and extrahepatic portal venous obstruction.
    Bhargava DK; Dasarathy S; Atmakuri SP; Dwivedi M
    J Gastroenterol Hepatol; 1990; 5(4):432-7. PubMed ID: 2129815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome after sclerotherapy with or without a beta-blocker for variceal bleeding in children.
    Sökücü S; Süoglu OD; Elkabes B; Saner G
    Pediatr Int; 2003 Aug; 45(4):388-94. PubMed ID: 12911472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study].
    Dollet JM; Champigneulle B; Patris A; Bigard MA; Gaucher P
    Gastroenterol Clin Biol; 1988 Mar; 12(3):234-9. PubMed ID: 3259521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. The PROVA Study Group.
    Hepatology; 1991 Dec; 14(6):1016-24. PubMed ID: 1959848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration.
    Vinel JP; Lamouliatte H; Cales P; Combis JM; Roux D; Desmorat H; Pradere B; Barjonet G; Quinton A
    Gastroenterology; 1992 May; 102(5):1760-3. PubMed ID: 1568586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.
    Lundell L; Leth R; Lind T; Lönroth H; Sjövall M; Olbe L
    Acta Chir Scand; 1990 Oct; 156(10):711-5. PubMed ID: 2264429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study.
    Lo GH; Lai KH; Lee SD; Tsai YT; Lo KJ
    J Gastroenterol Hepatol; 1993; 8(4):358-62. PubMed ID: 8374092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices.
    Krige JE; Kotze UK; Bornman PC; Shaw JM; Klipin M
    Ann Surg; 2006 Nov; 244(5):764-70. PubMed ID: 17060770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients.
    Krige JE; Bornman PC; Goldberg PA; Terblanche J
    Arch Surg; 2000 Nov; 135(11):1315-22. PubMed ID: 11074888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.
    Escorsell A; Bordas JM; del Arbol LR; Jaramillo JL; Planas R; Bañares R; Albillos A; Bosch J
    J Hepatol; 1998 Nov; 29(5):779-88. PubMed ID: 9833916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
    Sarin SK; Wadhawan M; Gupta R; Shahi H
    Dig Dis Sci; 2005 Aug; 50(8):1538-47. PubMed ID: 16110851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of endoscopic sclerotherapy on long-term management of oesophageal varices: a comparative study of results in patients with cirrhosis of the liver, non-cirrhotic portal fibrosis (NCPF) and extrahepatic portal venous obstruction (EHO).
    Bhargava DK; Dasarathy S; Sundaram KR; Ahuja RK
    J Gastroenterol Hepatol; 1991; 6(5):471-5. PubMed ID: 1932668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of emergency endoscopic sclerotherapy versus emergency portacaval shunt for acutely bleeding esophageal varices in cirrhosis.
    Orloff MJ; Isenberg JI; Wheeler HO; Haynes KS; Jinich-Brook H; Rapier R; Vaida F; Hye RJ
    J Am Coll Surg; 2009 Jul; 209(1):25-40. PubMed ID: 19651060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.